Showing results (341-350 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|November 28, 2020
Adjusting win statistics for dependent censoringGaohong Dong, Bo Huang, Duolao Wang, et al.Pharmaceutical Statistics|November 29, 2020
An application of the mixed-effects model and pattern mixture model to treatment groups with differential missingness suspected not-missing-at-randomMasahiko Gosho, Kazushi MaruoPharmaceutical Statistics|December 29, 2017
Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspectsDavid Dejardin, Paul Delmar, Charles Warne, et al.Pharmaceutical Statistics|December 17, 2013
Influence analysis on crossover design experiment in bioequivalence studiesYufen Huang, Bo-Shiang KePharmaceutical Statistics|December 18, 2013
An extension of the placebo-based pattern-mixture modelKaifeng LuPharmaceutical Statistics|January 8, 2022
Estimation of a treatment policy estimand for time to event data using data collected post discontinuation of randomised treatmentBenjamin Hartley, Thomas Drury, Sally Lettis, et al.Pharmaceutical Statistics|September 2, 2022
Should the two-trial paradigm still be the gold standard in drug assessment?Stella Jinran Zhan, Cornelia Ursula Kunz, Nigel StallardPharmaceutical Statistics|March 24, 2021
Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methodsLuke Ondijo Ouma, Michael J Grayling, Haiyan Zheng, et al.Pharmaceutical Statistics|February 17, 2021
Potential impact of COVID-19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA-TICS studyFlorian Lasch, Lorenzo Guizzaro, Lukas Aguirre Dávila, et al.Pharmaceutical Statistics|March 7, 2017
Balanced covariates with response adaptive randomizationBenjamin R Saville, Scott M BerryPageof 119